Two new retinoids for psoriasis.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D017255:Acitretin / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000505:Alopecia / Q000139:chemically induced; D002613:Cheilitis / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D016527:Drug Costs; D004347:Drug Interactions; D005243:Feces / Q000737:chemistry; D005782:Gels; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D011565:Psoriasis / Q000188:drug therapy*; D012176:Retinoids
D017255:Acitretin; D003879:Dermatologic Agents; D005782:Gels; D007641:Keratolytic Agents; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids